SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0000950103-15-000260
Filing Date
2015-01-12
Accepted
2015-01-12 17:28:00
Documents
5
Group Members
KNIGHT NEWCO 2, INC.SHIRE PLC

Document Format Files

Seq Description Document Type Size
1 FORM SC TO-C dp52541_sctoc.htm SC TO-C 70514
2 EXHIBIT 2.1 dp52541_ex0201.htm EX-2.1 657526
3 EXHIBIT 10.1 dp52541_ex1001.htm EX-10.1 2615634
4 EXHIBIT 99.1 dp52541_ex9901.htm EX-99.1 115183
5 GRAPHIC logo.jpg GRAPHIC 22596
  Complete submission text file 0000950103-15-000260.txt   3491670
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Subject) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-44877 | Film No.: 15522742
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 5 RIVERWALK, CITYWEST BUSINESS CAMPUS DUBLIN L2 24
Business Address 5 RIVERWALK, CITYWEST BUSINESS CAMPUS DUBLIN L2 24 353-1-429-7700
Shire Pharmaceutical Holdings Ireland Ltd. (Filed by) CIK: 0001590310 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC TO-C